India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

The company is also pinning its hopes on its ability to cross-sell the devices to hospitals and doctors who prescribe their drugs. Patel said Zydus is not only looking at organic growth but is ...

Like our moon, Deimos is tidally locked to Mars, meaning the same side always faces the planet—the only side visible to ...

(Image Credits: Pixabay) Zydus on Wednesday said that a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients.

Zydus will bring this critical medicine to the market to provide patients with important treatment alternatives for this extremely challenging condition, he added. Citing IQVIA MAT December 2024 data, ...

Zydus Lifesciences has introduced ANVIMO, a breakthrough medication for preventing Cytomegalovirus (CMV) infection in haematopoietic stem cell and kidney transplant patients. The drug, containing ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila ... with other drugs to treat a ...

Zydus will carry out early-stage development. (Image Credits: Pixabay) Zydus Lifesciences Limited on Tuesday announced its focus on the development of a combination vaccine against shigellosis and ...

Zydus Lifesciences Limited (Formerly known as ... cytotoxic (anti-cancer) medicines as well as active pharmacetical ingredients (API) for global markets.During the year 2005-06, the Company ...